Johnson & Johnson
JNJ · Salud · Next earnings: 13 Oct 2026 · Before the open · Q3 2026
Relevance 40/100 · Minor1-year price history
Source: Yahoo FinanceThe chart uses daily closes adjusted by the available provider. There may be delays, gaps or differences versus the official source.
Company
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech.
- Sector Healthcare · Drug Manufacturers - General
- Website https://www.jnj.com
What the market expects
8 analysts
How expectations have moved
Expectations: High
Expectativas elevadas: el consenso de BPA se ha revisado al alza un 2.3% en 30 días y cotiza a un 5% de su máximo de 52 semanas. Superar el consenso no garantiza una subida — el mercado puede tener ya descontado un buen resultado.
Prior behaviour
Historical moves describe typical magnitude, not a future direction.
Expected move
±4.9% (options)
“±X%” is the typical move size, not a forecast of direction.
Stock situation
Metrics to watch
- Ventas del fármaco o producto principal
- Guidance de ingresos anual
- Avances de pipeline / ensayos clínicos mencionados
- Margen operativo
- BPA e ingresos frente al consenso (sorpresa)
- Cambio en el guidance respecto al trimestre anterior
- Reacción del mercado frente al movimiento histórico y al implícito
Relevance breakdown
Disclaimer
Radar Acciones provides information and analysis tools, not personalised investment advice. Consensus and expectations data describe the setup around an event with objective figures; they must never be read as a forecast of direction or price.